@inproceedings{inproceedings, title  = {{Nab-paclitaxel or docetaxel as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): a cost utility analysis in five European countries}},

 url = {{}},

 year = {{2008}},

 month = {{5}},

 author = {{Dranitsaris G and Lidgren M and Lundkvist J and Coleman RE}},

 doi = {{10.1200/jco.2008.26.15_suppl.6571}},

 volume = {{26}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2025/10/10}}}